Seger starts development of intracorporeal anastomosis laparoscopic device

January 6, 2022 (Last Updated January 6th, 2022 15:19)

LAP IA 60 aligns, closes and staples the common opening for intracorporeal anastomosis quickly and securely.

Seger starts development of intracorporeal anastomosis laparoscopic device
The new laparoscopic stapler is designed for intracorporeal anastomosis. Credit: Seger Surgical Solutions / PRNewswire.

Seger Surgical Solutions has commenced the development of its next-generation laparoscopic bowel closure device for intracorporeal anastomosis.

The new device, named LAP IA 60, is capable of aligning, closing and stapling the common opening for intracorporeal anastomosis quickly, securely and without the need for suturing.

Compared to suturing, which takes roughly 15 to 20 minutes, the Seger device closes the enterotomy in less than two minutes.

In a statement, Seger said: “Extracorporeal anastomosis has been shown to result in longer hospital stays and increased hospitalisation costs due to post-operative complications, including higher post-op hernia rates with midline incisions, increased pain and worse cosmesis due to larger incisions.”

Inserted through a standard 12-millimetre trocar, the closure device allows surgeons to perform complete laparoscopic bowel anastomoses for improved clinical results.

This also provides better outcomes, improves patient care and reduces complications as well as healthcare costs.

Bowel resection surgery involves the removal of a part of the intestine followed by the surgeon creating a common opening (enterotomy) in the two bowel sections for connecting them (anastomosis).

Due to challenges presented by laparoscopic suturing, most resections and anastomoses are now performed outside the abdomen (extracorporeal).

Last October, Medtronic obtained CE mark for its Hugo robotic-assisted surgery (RAS) system to be used in procedures related to urology and gynaecology.

It comes with a Cloud-based surgical video recording option that is enabled through the Touch Surgery Enterprise.

Commercially available in Europe, the Hugo RAS system was designed to address the cost and utilisation barriers that have restricted the adoption of robotic surgery for the last 20 years.